LivaNova PLC (LIVN)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $5.03B
Last updated: Nov 17, 2026 at 11:06 AM ET
LivaNova PLC (LIVN) Stock Forecast
Analysts expect LivaNova (LIVN) to earn $4.43 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.53B. Of 11 analysts, 9 rate the stock Buy or Strong Buy, 2 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 9 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 11 ratings average 1.91, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 82% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 27.3% |
| Buy | 6 | 54.5% |
| Hold | 2 | 18.2% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 11
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 6.8% and revenue estimates rise 7.2%.
- Fiscal year ending Dec 31, 2026
- $4.43
- EPS consensus, revenue $1.53B
- Fiscal year ending Dec 31, 2027
- $4.73
- EPS consensus, revenue $1.64B
- Next report
- Feb 23, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $4.43 | $4.40 to $4.46 | 10 | $1.53B | $1.50B to $1.54B | 10 |
| Dec 31, 2027 | $4.73 | $4.46 to $4.91 | 10 | $1.64B | $1.60B to $1.67B | 10 |
Quarterly Estimates
The EPS consensus rises from $1.00 for the quarter ending Dec 31, 2026 to $1.06 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.00 | $0.92 to $1.16 | 12 | $396.96M | $377.99M to $414.75M | 11 |
| Mar 31, 2027 | $1.06 | $0.99 to $1.13 | 6 | $386.54M | $384.90M to $389.40M | 5 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 17 upward and 1 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 9 | 0 |
| Fiscal year ending Dec 31, 2027 | 7 | 1 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 2.1% from $4.34.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $4.43 | $4.36 | $4.36 | $4.36 | $4.34 | +2.1% |
| Fiscal year ending Dec 31, 2027 | $4.73 | $4.68 | $4.68 | $4.68 | $4.68 | +1.0% |
| Quarter ending Mar 31, 2027 | $1.06 | $1.07 | $1.07 | $1.07 | $1.07 | -1.0% |
Frequently Asked Questions About LIVN
What is the LIVN stock forecast?
Consensus analyst estimates put LivaNova's EPS at $4.43 for the fiscal year ending Dec 31, 2026, on revenue of $1.53B. The consensus rating from 11 analysts is Buy.
How do analysts rate LIVN stock?
Of 11 analysts covering LivaNova, 3 rate it Strong Buy, 6 Buy, 2 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from LIVN next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $4.43, with estimates from $4.40 to $4.46 from 10 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $4.73, with estimates from $4.46 to $4.91 from 10 analysts.
What revenue do analysts expect from LivaNova next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.53B, with estimates from $1.50B to $1.54B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.64B, with estimates from $1.60B to $1.67B.
How many analysts cover LIVN?
11 analysts rate LivaNova stock, and 10 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
LIVN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts